From: Undifferentiated uterine sarcoma : experience of a single center
Clinical Characteristics | n | % |
---|---|---|
Age (years) | ||
<50 | 10 | 34.5 |
≥50 | 19 | 65.5 |
Primary symptoms | ||
Vaginal bleeding | 19 | 65.5 |
Physical examination | 8 | 27.6 |
Lower abdominal pain | 2 | 6.9 |
BMI (kg/m2) | ||
<24 | 15 | 51.7 |
≥24 | 14 | 48.3 |
Tumor size (cm) | ||
<5 | 2 | 6.9 |
≥5, < 10 | 13 | 44.8 |
≥10 | 14 | 48.3 |
FIGO stage | ||
I | 17 | 58.6 |
II | 5 | 17.2 |
III | 4 | 13.8 |
IV | 3 | 10.3 |
Neoadjuvant chemotherapy | ||
Yes | 4 | 13.8 |
No | 25 | 86.2 |
Hysterectomy | ||
Total hysterectomy | 22 | 75.9 |
Sub-radical hysterectomy | 3 | 10.3 |
Radical hysterectomy | 2 | 6.9 |
No | 2 | 6.9 |
Lymphadenectomy | ||
Pelvic | 10 | 34.5 |
Pelvic + pre-aortic | 7 | 24.1 |
No | 12 | 41.4 |
Omentectomy | ||
Yes | 8 | 27.6 |
No | 21 | 72.4 |
Myometrial invasion | ||
<1/2 | 11 | 37.9 |
≥1/2 | 16 | 55.2 |
NA | 2 | 6.9 |
Cervical involvement | ||
Yes | 4 | 13.8 |
No | 23 | 79.3 |
NA | 2 | 6.9 |
Pelvic lymph node metastasis | ||
Yes | 2 | 6.9 |
No | 15 | 51.7 |
NA | 12 | 41.4 |
Pre-aortic lymph node metastasis | ||
Yes | 1 | 3.4 |
No | 6 | 20.7 |
NA | 22 | 75.9 |
Adjuvant treatment | ||
Chemotherapy | 22 | 75.9 |
Chemotherapy + radiotherapy | 1 | 3.4 |
None | 6 | 20.7 |